MarketBeat Instant News Alerts 2 hours agoSalesforce, Inc. (NYSE:CRM) Stake Increased by Family Management CorpMarketBeatFamily Management Corp lifted its stake in shares of Salesforce, Inc. (NYSE:CRM - Free Report) by 4.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 21,600 shares of the CRM provider's stock after purchasing an additional 918 shares during the perNYSE:CRMRead Salesforce, Inc. (NYSE:CRM) Stake Increased by Family Management Corp2 hours agoFullcircle Wealth LLC Invests $895,000 in Eli Lilly and Company (NYSE:LLY)MarketBeatFullcircle Wealth LLC purchased a new stake in Eli Lilly and Company (NYSE:LLY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 1,159 shares of the company's stock, valued at approximately NYSE:LLYRead Fullcircle Wealth LLC Invests $895,000 in Eli Lilly and Company (NYSE:LLY)2 hours agoFundsmith Investment Services LTD. Has $487.33 Million Stake in Visa Inc. (NYSE:V)MarketBeatFundsmith Investment Services LTD. decreased its position in Visa Inc. (NYSE:V - Free Report) by 15.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,541,994 shares of the credit-card processor's stock aNYSE:VRead Fundsmith Investment Services LTD. Has $487.33 Million Stake in Visa Inc. (NYSE:V)2 hours agoPiper Sandler Lowers CCC Intelligent Solutions (NYSE:CCCS) Price Target to $9.00MarketBeatPiper Sandler lowered their price target on shares of CCC Intelligent Solutions from $11.00 to $9.00 and set a "neutral" rating on the stock in a report on Wednesday.NYSE:CCCSRead Piper Sandler Lowers CCC Intelligent Solutions (NYSE:CCCS) Price Target to $9.002 hours agoPiper Sandler Boosts Klaviyo (NYSE:KVYO) Price Target to $40.00MarketBeatPiper Sandler boosted their price objective on shares of Klaviyo from $35.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday.NYSE:KVYORead Piper Sandler Boosts Klaviyo (NYSE:KVYO) Price Target to $40.002 hours agoBlackLine (NASDAQ:BL) Given New $50.00 Price Target at Piper SandlerMarketBeatPiper Sandler upped their price objective on shares of BlackLine from $46.00 to $50.00 and gave the company a "neutral" rating in a report on Wednesday.NASDAQ:BLRead BlackLine (NASDAQ:BL) Given New $50.00 Price Target at Piper Sandler Trending News1Cantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) Sees Strong Trading Volume - Still a Buy?2Raymond James Financial Inc. Acquires New Holdings in QuantumScape Co. (NYSE:QS)3ArrowMark Colorado Holdings LLC Increases Stock Position in BlackBerry Limited (NYSE:BB)4131,600 Shares in SoundHound AI, Inc. (NASDAQ:SOUN) Bought by Bulltick Wealth Management LLC5Wolfspeed (NYSE:WOLF) Shares Gap Up - Time to Buy?6Baker BROS. Advisors LP Purchases 464,936 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)7What is Wedbush's Forecast for AMC Q1 Earnings?8Raymond James Financial Inc. Acquires Shares of 63,961 AST SpaceMobile, Inc. (NASDAQ:ASTS) All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoIntapp (NASDAQ:INTA) Given New $70.00 Price Target at Piper SandlerMarketBeatNASDAQ:INTARead Intapp (NASDAQ:INTA) Given New $70.00 Price Target at Piper Sandler2 hours agoAudioCodes' (AUDC) "Buy" Rating Reaffirmed at Needham & Company LLCMarketBeatNASDAQ:AUDCRead AudioCodes' (AUDC) "Buy" Rating Reaffirmed at Needham & Company LLC2 hours agoChardan Capital Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG)MarketBeatNASDAQ:DRUGRead Chardan Capital Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG)2 hours agoPraxis Precision Medicines (NASDAQ:PRAX) Now Covered by Chardan CapitalMarketBeatNASDAQ:PRAXRead Praxis Precision Medicines (NASDAQ:PRAX) Now Covered by Chardan Capital2 hours agoChardan Capital Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $82.00MarketBeatNASDAQ:CRSPRead Chardan Capital Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $82.002 hours agoChardan Capital Initiates Coverage on Xenon Pharmaceuticals (NASDAQ:XENE)MarketBeatNASDAQ:XENERead Chardan Capital Initiates Coverage on Xenon Pharmaceuticals (NASDAQ:XENE)2 hours agoDHT's (DHT) Buy Rating Reiterated at Jefferies Financial GroupMarketBeatNYSE:DHTRead DHT's (DHT) Buy Rating Reiterated at Jefferies Financial Group2 hours agoAvidity Biosciences (NASDAQ:RNA) Receives "Buy" Rating from Chardan CapitalMarketBeatNASDAQ:RNARead Avidity Biosciences (NASDAQ:RNA) Receives "Buy" Rating from Chardan Capital2 hours agoKrystal Biotech's (KRYS) Buy Rating Reiterated at Chardan CapitalMarketBeatNASDAQ:KRYSRead Krystal Biotech's (KRYS) Buy Rating Reiterated at Chardan Capital2 hours agoDiscover Financial Services' (DFS) "Hold" Rating Reaffirmed at Jefferies Financial GroupMarketBeatNYSE:DFSRead Discover Financial Services' (DFS) "Hold" Rating Reaffirmed at Jefferies Financial Group2 hours agoBank of America Q2 EPS Forecast Lowered by Zacks ResearchMarketBeatNYSE:BACRead Bank of America Q2 EPS Forecast Lowered by Zacks Research2 hours agoUber Technologies (NYSE:UBER) Price Target Raised to $98.00MarketBeatNYSE:UBERRead Uber Technologies (NYSE:UBER) Price Target Raised to $98.002 hours agoNeedham & Company LLC Lowers IonQ (NYSE:IONQ) Price Target to $50.00MarketBeatNYSE:IONQRead Needham & Company LLC Lowers IonQ (NYSE:IONQ) Price Target to $50.002 hours agoCrowdStrike (NASDAQ:CRWD) Given Buy Rating at Rosenblatt SecuritiesMarketBeatNASDAQ:CRWDRead CrowdStrike (NASDAQ:CRWD) Given Buy Rating at Rosenblatt Securities2 hours agoFWL Investment Management LLC Raises Stake in Invesco QQQ (NASDAQ:QQQ)MarketBeatNASDAQ:QQQRead FWL Investment Management LLC Raises Stake in Invesco QQQ (NASDAQ:QQQ)2 hours agoFullcircle Wealth LLC Has $1.56 Million Holdings in Novo Nordisk A/S (NYSE:NVO)MarketBeatNYSE:NVORead Fullcircle Wealth LLC Has $1.56 Million Holdings in Novo Nordisk A/S (NYSE:NVO)2 hours agoFWL Investment Management LLC Buys 2,258 Shares of Alphabet Inc. (NASDAQ:GOOG)MarketBeatNASDAQ:GOOGRead FWL Investment Management LLC Buys 2,258 Shares of Alphabet Inc. (NASDAQ:GOOG)2 hours agoFullcircle Wealth LLC Boosts Stake in Johnson & Johnson (NYSE:JNJ)MarketBeatNYSE:JNJRead Fullcircle Wealth LLC Boosts Stake in Johnson & Johnson (NYSE:JNJ)2 hours agoFullcircle Wealth LLC Reduces Position in Broadcom Inc. (NASDAQ:AVGO)MarketBeatNASDAQ:AVGORead Fullcircle Wealth LLC Reduces Position in Broadcom Inc. (NASDAQ:AVGO)2 hours agoFullcircle Wealth LLC Sells 2,805 Shares of United Parcel Service, Inc. (NYSE:UPS)MarketBeatNYSE:UPSRead Fullcircle Wealth LLC Sells 2,805 Shares of United Parcel Service, Inc. (NYSE:UPS)2 hours agoFundsmith Investment Services LTD. Has $434.33 Million Position in Philip Morris International Inc. (NYSE:PM)MarketBeatNYSE:PMRead Fundsmith Investment Services LTD. Has $434.33 Million Position in Philip Morris International Inc. (NYSE:PM)2 hours agoCircle Wealth Management LLC Lowers Stock Position in Micron Technology, Inc. (NASDAQ:MU)MarketBeatNASDAQ:MURead Circle Wealth Management LLC Lowers Stock Position in Micron Technology, Inc. (NASDAQ:MU)2 hours agoMeta Platforms, Inc. (NASDAQ:META) Shares Sold by Fundsmith Investment Services LTD.MarketBeatNASDAQ:METARead Meta Platforms, Inc. (NASDAQ:META) Shares Sold by Fundsmith Investment Services LTD.2 hours agoFWL Investment Management LLC Trims Stock Holdings in Advanced Micro Devices, Inc. (NASDAQ:AMD)MarketBeatNASDAQ:AMDRead FWL Investment Management LLC Trims Stock Holdings in Advanced Micro Devices, Inc. (NASDAQ:AMD) Featured Articles and OffersRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsBy Ryan Hasson | May 5, 2025View Rocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsURGENT: Someone's Moving Gold Out of London...From Golden Portfolio(Ad)View URGENT: Someone's Moving Gold Out of London...3 Mid-Cap Medical Stocks Outperforming the MarketBy Ryan Hasson | May 6, 2025View 3 Mid-Cap Medical Stocks Outperforming the MarketUPS Stock Forecast: Rebound Underway for United Parcel Service?By Thomas Hughes | May 4, 2025View UPS Stock Forecast: Rebound Underway for United Parcel Service?Why Wells Fargo Is Buying $40 Billion of Its Own StockBy Gabriel Osorio-Mazilli | May 6, 2025View Why Wells Fargo Is Buying $40 Billion of Its Own StockWatch This Robotics Demo Before July 23rdFrom Brownstone Research(Ad)View Watch This Robotics Demo Before July 23rdCantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) Sees Strong Trading Volume - Still a Buy?By MarketBeat | May 8, 2025View Cantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) Sees Strong Trading Volume - Still a Buy?Raymond James Financial Inc. Acquires New Holdings in QuantumScape Co. (NYSE:QS)By MarketBeat | May 8, 2025View Raymond James Financial Inc. Acquires New Holdings in QuantumScape Co. (NYSE:QS) Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
